Optimax Access has a committed team of health economists and research analysts with more than 10 years’ international experience of the healthcare industry and health outcomes sector. Our multi-disciplinary team use our experience gained in the pharmaceutical industry, academia and health services worldwide to provide its clients with a comprehensive range of services related to health outcomes research.

In Optimax Access we are proud to serve our clients.

We offer a wide variety of evidence review and development projects to support your products and researches in our offices in the UK, US and Canada; the following are just a few examples: 


Review of Evidence
•	Systematic reviews and interpretation of clinical and economic evidence
•	Structured and targeted literature reviews (e.g. burden of illness, unmet needs assessments, health technology assessment (HTA))
•	Network meta-analyses and indirect treatment comparisons

Economic Evidence Development
•	Cost-effectiveness and cost-utility models
•	Early economic modelling and threshold analyses
•	Within-trial patient-level data analysis
•	Cohort models and individual patient-level simulations
•	Global economic models or HTA agency specific models
•	Adapting economic models to reflect intra-country and regional differences
•	Budget impact models
•	Survival modelling and extrapolation
•	Health outcome studies (Health-related quality of life/utility)

Strategy Planning
•	Methodological and strategic advice
•	Portfolio planning
•	Preparation for formal HTA scientific advice
•	Critical review of your HTA submission
•	Review, critique and development of HEOR evidence generation plans (e.g. clinical trial design and outcomes assessment/instrument selection, payer evidence planning)
•	Review and critique of existing economic models and HTA evidence materials

Optimax Access

Org chart

Teams

Offices